These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26834750)

  • 21. High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.
    Andrews SF; Kaur K; Pauli NT; Huang M; Huang Y; Wilson PC
    J Virol; 2015 Mar; 89(6):3308-17. PubMed ID: 25589639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.
    Nayak JL; Richards KA; Yang H; Treanor JJ; Sant AJ
    J Infect Dis; 2015 May; 211(9):1408-17. PubMed ID: 25378637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines.
    Sridhar S
    Front Immunol; 2016; 7():195. PubMed ID: 27242800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-mediated protection in influenza infection.
    Thomas PG; Keating R; Hulse-Post DJ; Doherty PC
    Emerg Infect Dis; 2006 Jan; 12(1):48-54. PubMed ID: 16494717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen presentation and the regulation of CD4 memory generation to influenza.
    Jelley-Gibbs D; Haynes L; Swain S
    Expert Rev Clin Immunol; 2006 Jul; 2(4):601-11. PubMed ID: 20477616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination with cell immunoglobulin mucin-1 antibodies and inactivated influenza enhances vaccine-specific lymphocyte proliferation, interferon-gamma production and cross-strain reactivity.
    Soo Hoo W; Jensen ER; Saadat A; Nieto D; Moss RB; Carlo DJ; Moll T
    Clin Exp Immunol; 2006 Jul; 145(1):123-9. PubMed ID: 16792682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Function of Protective and Pathologic Memory CD4 T Cells.
    Jaigirdar SA; MacLeod MK
    Front Immunol; 2015; 6():456. PubMed ID: 26441961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aging of the CD4 T Cell Compartment.
    Lefebvre JS; Haynes L
    Open Longev Sci; 2012 Jan; 6():83-91. PubMed ID: 24839469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4 T cell epitope specificity determines follicular versus non-follicular helper differentiation in the polyclonal response to influenza infection or vaccination.
    Knowlden ZA; Sant AJ
    Sci Rep; 2016 Jun; 6():28287. PubMed ID: 27329272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
    DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
    Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avian and Human Seasonal Influenza Hemagglutinin Proteins Elicit CD4 T Cell Responses That Are Comparable in Epitope Abundance and Diversity.
    DiPiazza A; Richards K; Poulton N; Sant AJ
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28100497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza.
    Devarajan P; Bautista B; Vong AM; McKinstry KK; Strutt TM; Swain SL
    Front Immunol; 2016; 7():136. PubMed ID: 27148257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pandemic 2009 H1N1 Influenza Venus reporter virus reveals broad diversity of MHC class II-positive antigen-bearing cells following infection in vivo.
    DiPiazza A; Nogales A; Poulton N; Wilson PC; Martínez-Sobrido L; Sant AJ
    Sci Rep; 2017 Sep; 7(1):10857. PubMed ID: 28883436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino acid changes in PB2 and HA affect the growth of a recombinant influenza virus expressing a fluorescent reporter protein.
    Katsura H; Fukuyama S; Watanabe S; Ozawa M; Neumann G; Kawaoka Y
    Sci Rep; 2016 Feb; 6():19933. PubMed ID: 26847414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel universal influenza virus vaccine approaches.
    Krammer F
    Curr Opin Virol; 2016 Apr; 17():95-103. PubMed ID: 26927813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.
    Sant AJ; DiPiazza AT; Nayak JL; Rattan A; Richards KA
    Immunol Rev; 2018 Jul; 284(1):91-105. PubMed ID: 29944766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balancing Immune Protection and Immune Pathology by CD8(+) T-Cell Responses to Influenza Infection.
    Duan S; Thomas PG
    Front Immunol; 2016; 7():25. PubMed ID: 26904022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza B vaccine lineage selection--an optimized trivalent vaccine.
    Mosterín Höpping A; Fonville JM; Russell CA; James S; Smith DJ
    Vaccine; 2016 Mar; 34(13):1617-1622. PubMed ID: 26896685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate.
    Tran EE; Podolsky KA; Bartesaghi A; Kuybeda O; Grandinetti G; Wohlbold TJ; Tan GS; Nachbagauer R; Palese P; Krammer F; Subramaniam S
    mBio; 2016 Mar; 7(2):e00257. PubMed ID: 27006464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.